Randall E Harris

Summary

Affiliation: The Ohio State University
Country: USA

Publications

  1. ncbi request reprint Chemoprevention of lung cancer by non-steroidal anti-inflammatory drugs among cigarette smokers
    Randall E Harris
    The Ohio State University College of Medicine and Public Health, Columbus, OH 43210 1240, USA
    Oncol Rep 9:693-5. 2002
  2. ncbi request reprint Cancer chemoprevention by cyclooxygenase 2 (COX-2) blockade: results of case control studies
    Randall E Harris
    Ohio State University College of Medicine and School of Public Health, A150B Starling Loving Hall, 320 W 10th Avenue, Columbus, OH 43210, USA
    Subcell Biochem 42:193-212. 2007
  3. ncbi request reprint Antiangiogenesis: New Frontiers in Therapeutic Development--IBC's Fourth Annual International Symposium
    Randall E Harris
    Ohio State University Medical Center, Division of Epidemiology, 320 West 10th Avenue, A 150B Starling Loving Hall, Columbus, OH 43210, USA
    IDrugs 9:834-6. 2006
  4. pmc Similar reductions in the risk of human colon cancer by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors
    Randall E Harris
    The Ohio State University College of Medicine and Public Health, 320 West 10th Avenue, Columbus, Ohio 43210 1240, USA
    BMC Cancer 8:237. 2008
  5. pmc Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors
    Randall E Harris
    The Ohio State University College of Medicine and Public Health, Columbus, Ohio 43210 1240, USA
    BMC Cancer 6:27. 2006
  6. ncbi request reprint Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review)
    Randall E Harris
    College of Medicine and Public Health, The Ohio State University, 320 West 10th Avenue, Columbus, OH 43210 1240, USA
    Oncol Rep 13:559-83. 2005
  7. ncbi request reprint Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative
    Randall E Harris
    The Ohio State University College of Medicine and Public Health, Columbus, Ohio 43210 1240, USA
    Cancer Res 63:6096-101. 2003
  8. pmc Reduced risk of human lung cancer by selective cyclooxygenase 2 (COX-2) blockade: results of a case control study
    Randall E Harris
    The Ohio State University College of Medicine and School of Public Health, Columbus, OH 43210, USA
    Int J Biol Sci 3:328-34. 2007
  9. ncbi request reprint Evidence of population mixing based on the geographical distribution of childhood leukemia in Ohio
    Brenda R Clark
    Division of Health Behavior and Health Promotion, School of Public Health, The Ohio State University, Ohio 43210, USA
    Pediatr Blood Cancer 49:797-802. 2007
  10. ncbi request reprint Comorbidity among the morbidly obese: a comparative study of 2002 U.S. hospital patient discharges
    Susanne K Scott
    Division of Epidemiology, School of Public Health, The Ohio State University, Columbus, Ohio 43210, USA
    Surg Obes Relat Dis 2:105-11. 2006

Detail Information

Publications14

  1. ncbi request reprint Chemoprevention of lung cancer by non-steroidal anti-inflammatory drugs among cigarette smokers
    Randall E Harris
    The Ohio State University College of Medicine and Public Health, Columbus, OH 43210 1240, USA
    Oncol Rep 9:693-5. 2002
    ..22), and for the individual compounds, aspirin (RR, 0.25) and ibuprofen (RR, 0.39). These results combined with the current molecular evidence suggest that regular NSAID intake may prevent tobacco carcinogenesis through COX-2 blockade...
  2. ncbi request reprint Cancer chemoprevention by cyclooxygenase 2 (COX-2) blockade: results of case control studies
    Randall E Harris
    Ohio State University College of Medicine and School of Public Health, A150B Starling Loving Hall, 320 W 10th Avenue, Columbus, OH 43210, USA
    Subcell Biochem 42:193-212. 2007
    ..This investigation demonstrates that COX-2 blocking agents have strong potential for the chemoprevention of cancers of the breast, prostate, colon and lung...
  3. ncbi request reprint Antiangiogenesis: New Frontiers in Therapeutic Development--IBC's Fourth Annual International Symposium
    Randall E Harris
    Ohio State University Medical Center, Division of Epidemiology, 320 West 10th Avenue, A 150B Starling Loving Hall, Columbus, OH 43210, USA
    IDrugs 9:834-6. 2006
  4. pmc Similar reductions in the risk of human colon cancer by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors
    Randall E Harris
    The Ohio State University College of Medicine and Public Health, 320 West 10th Avenue, Columbus, Ohio 43210 1240, USA
    BMC Cancer 8:237. 2008
    ....
  5. pmc Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors
    Randall E Harris
    The Ohio State University College of Medicine and Public Health, Columbus, Ohio 43210 1240, USA
    BMC Cancer 6:27. 2006
    ....
  6. ncbi request reprint Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review)
    Randall E Harris
    College of Medicine and Public Health, The Ohio State University, 320 West 10th Avenue, Columbus, OH 43210 1240, USA
    Oncol Rep 13:559-83. 2005
    ..This review provides compelling and converging evidence that regular intake of NSAIDs that non-selectively block COX-2 protects against the development of many types of cancer...
  7. ncbi request reprint Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative
    Randall E Harris
    The Ohio State University College of Medicine and Public Health, Columbus, Ohio 43210 1240, USA
    Cancer Res 63:6096-101. 2003
    ..Our results indicate that the regular use of aspirin, ibuprofen, or other NSAIDs may have a significant chemopreventive effect against the development of breast cancer and underscore the need for clinical trials to confirm this effect...
  8. pmc Reduced risk of human lung cancer by selective cyclooxygenase 2 (COX-2) blockade: results of a case control study
    Randall E Harris
    The Ohio State University College of Medicine and School of Public Health, Columbus, OH 43210, USA
    Int J Biol Sci 3:328-34. 2007
    ..36, 95% CI=0.53-3.37). This investigation demonstrates for the first time that selective COX-2 blocking agents have strong potential for the chemoprevention of human lung cancer...
  9. ncbi request reprint Evidence of population mixing based on the geographical distribution of childhood leukemia in Ohio
    Brenda R Clark
    Division of Health Behavior and Health Promotion, School of Public Health, The Ohio State University, Ohio 43210, USA
    Pediatr Blood Cancer 49:797-802. 2007
    ..This ecologic study examined the geographic distribution of childhood leukemias in Ohio, 1996-2000, among children aged 0-19 for evidence that population mixing may be a factor...
  10. ncbi request reprint Comorbidity among the morbidly obese: a comparative study of 2002 U.S. hospital patient discharges
    Susanne K Scott
    Division of Epidemiology, School of Public Health, The Ohio State University, Columbus, Ohio 43210, USA
    Surg Obes Relat Dis 2:105-11. 2006
    ..This study compares demographic characteristics and selected comorbid conditions of morbidly obese patients discharged after surgical obesity procedures and morbidly obese patients discharged after all other hospital procedures...
  11. ncbi request reprint Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer
    Randall E Harris
    College of Medicine and School of Public Health, Center of Molecular Epidemiology and Environmental Health, The Ohio State University Medical Center, 310 West 10th Avenue, Columbus, Ohio 43210 1240, USA
    Subcell Biochem 42:93-126. 2007
    ....
  12. ncbi request reprint Does the dose make the poison?
    Randall E Harris
    Science 308:203. 2005
  13. ncbi request reprint Breast cancer screening and diagnosis
    Therese B Bevers
    University of Texas, M D Anderson Cancer Center, Houston, TX 77030, USA
    J Natl Compr Canc Netw 4:480-508. 2006
  14. ncbi request reprint Non-Hodgkin's lymphoma and nonsteroidal anti-inflammatory drugs: a confounding problem?
    Randall E Harris
    Int J Cancer 110:150-1; author reply 152. 2004